Home Cart Sign in  
Chemical Structure| 885220-61-1 Chemical Structure| 885220-61-1

Structure of Verucerfont
CAS No.: 885220-61-1

Chemical Structure| 885220-61-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

GSK561679 is a CRF-1 antagonist. Verucerfont blocks the CRH-1 receptor, and so reduces ACTH release following chronic stress. It is under investigation as a potential treatment for alcoholism.

Synonyms: GSK561679

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Verucerfont

CAS No. :885220-61-1
Formula : C22H26N6O2
M.W : 406.48
SMILES Code : CC[C@H](NC1=CC(C)=NC2=C(C3=CC=C(OC)C=C3C)C(C)=NN12)C4=NC(C)=NO4
Synonyms :
GSK561679
MDL No. :MFCD19443727

Safety of Verucerfont

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338

Related Pathways of Verucerfont

GPCR

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT01814332 Stress Disorders, Post-traumat... More >>ic Less << Phase 2 Completed - United States, California ... More >> San Francisco VA Medical Center, San Francisco, CA San Francisco, California, United States, 94121 Less <<
NCT01814332 - Completed - -
NCT01059227 - Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02349503 Congenital Adrenal Hyperplasia Phase 1 Withdrawn October 2015 United States, Michigan ... More >> Ann Arbor, Michigan, United States, 48109 United States, Washington Seattle, Washington, United States, 98105 Less <<
NCT00555139 Social Phobia Phase 1 Completed - Spain ... More >> GSK Investigational Site Barcellona, Spain, 08025 GSK Investigational Site Barcelona, Spain, 08025 GSK Investigational Site Barcelona, Spain, 08035 GSK Investigational Site Barcelona, Spain, E-08003 GSK Investigational Site Barcelona, Spain GSK Investigational Site Hospitalet de Llobregat, Spain, 08907 GSK Investigational Site Mataro (Barcelona), Spain GSK Investigational Site Sabadell (Barcelona), Spain, 08208 GSK Investigational Site Terrassa - Barcelona, Spain, 08227 Less <<
NCT00513565 Depressive Disorder and Anxiet... More >>y Disorders Less << Phase 1 Completed - United States, California ... More >> GSK Investigational Site La Jolla, California, United States, 92037 Less <<
NCT01187511 Alcohol Dependence Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00426608 Depressive Disorder and Anxiet... More >>y Disorders Less << Phase 1 Completed - United Kingdom ... More >> GSK Investigational Site Cambridge, Cambridgeshire, United Kingdom, CB2 0QQ Less <<
NCT01187511 - Completed - -
NCT00539136 Healthy Subjects Phase 1 Completed - United States, Kentucky ... More >> GSK Investigational Site Lexington, Kentucky, United States, 40503 Less <<
NCT00733980 Depressive Disorder, Major Phase 2 Completed - United States, California ... More >> GSK Investigational Site Cerritos, California, United States, 90703 GSK Investigational Site San Diego, California, United States, 92108 GSK Investigational Site Torrance, California, United States, 90502 United States, Florida GSK Investigational Site Jacksonville, Florida, United States, 32216 GSK Investigational Site Miami, Florida, United States, 33125 United States, Georgia GSK Investigational Site Atlanta, Georgia, United States, 30322 GSK Investigational Site Marietta, Georgia, United States, 30060 United States, Illinois GSK Investigational Site Chicago, Illinois, United States, 60612 GSK Investigational Site Skokie, Illinois, United States, 60076 United States, Louisiana GSK Investigational Site Shreveport, Louisiana, United States, 71104 United States, Maryland GSK Investigational Site Rockville, Maryland, United States, 20852 United States, New Mexico GSK Investigational Site Albuquerque, New Mexico, United States, 87109 United States, North Carolina GSK Investigational Site Raleigh, North Carolina, United States, 27609 United States, Ohio GSK Investigational Site Cincinnati, Ohio, United States, 45219-0516 United States, Pennsylvania GSK Investigational Site Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee GSK Investigational Site Memphis, Tennessee, United States, 38119 United States, Wisconsin GSK Investigational Site Brown Deer, Wisconsin, United States, 53223 GSK Investigational Site Madison, Wisconsin, United States, 53719 Less <<
NCT00511563 Irritable Bowel Syndrome Phase 2 Withdrawn(Cancelled before act... More >>ive due to the results of emerging scientific data) Less << - -
NCT01018992 - Completed - -
NCT01018992 Stress Disorders, Post-Traumat... More >>ic Less << Phase 2 Completed - United States, California ... More >> Stress and Health Research Program, San Francisco VA Medical Center, University of California San Francisco San Francisco, California, United States, 94121 United States, Georgia Emory University Atlanta, Georgia, United States, 30306 United States, New York Mount Sinai School of Medicine New York, New York, United States, 10029 United States, Texas Baylor College of Medicine Houston, Texas, United States, 77030 Less <<
NCT00733980 - Completed - -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.46mL

0.49mL

0.25mL

12.30mL

2.46mL

1.23mL

24.60mL

4.92mL

2.46mL

 

Historical Records

Categories